Open-label Extension Study of ADP101
Clinical trial NCT05243719 · TERMINATED
Trial details
- NCT number
- NCT05243719
- Sponsor
- Alladapt Immunotherapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2024-02-27
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.